Indeed, the use of animal-derived natural ACTH to treat glomerular disease has been associated with de novo formation of neutralizing antibodies in some sensitive patients, followed by an acquired resistance to ACTH therapy (Wang et al., 2017; Shrivastava et al., 2020). Here, POMC is linked to glomerular disorder.